Page 6 - Vaxcyte Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vaxcyte, Inc (NASDAQ:PCVX) Given Average Rating of Buy by Brokerages

Vaxcyte, Inc (NASDAQ:PCVX) Given Average Rating of Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew guggenhimeMikhail eydelmanCantor fitzgeraldSecurities exchange commissionNeedham companyBridgefront capitalRussell investments group ltdVaxcyte incGroupa streptococcusVanguard personalized indexing managementGet free reportExchange commissionInvestments groupGet freeVaxcyte daily

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Janet graesserJennifer zibudaCorporate communicationsGroupa strepSutro biopharma incVaxcyte incAnnual needham virtual healthcareAnnual needham virtual healthcare conferenceSutro biopharmaSenior directorVice president

Certain Pre-Funded Warrants of Vaxcyte, Inc are subject to a Lock-Up Agreement Ending on 31-MAR-2024

Certain Pre-Funded Warrants of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 31-MAR-2024. These Pre-Funded Warrants will be under lockup for 61 days starting from 30-JAN-2024 to.

Vaxcyte incBofa securities incCertain pre funded warrantsLock up agreement endingPre funded warrantsBofa securitiesSecurities act

Vaxcyte, Inc (NASDAQ:PCVX) Receives $78 50 Consensus PT from Brokerages

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been assigned an average recommendation of “Buy” from the five ratings firms that are currently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued a report […]

United statesAndrew guggenhimeGroup plcGroupa streptococcusCantor fitzgeraldGoldman sachs group incChartwell investment partnersVaxcyte company profileNeedham companyBarclays plcEventide asset managementVaxcyte incGet free reportSachs groupAsset managementInvestment partners

Vaxcyte, Inc (NASDAQ:PCVX) Given Average Rating of Buy by Brokerages

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average recommendation of “Buy” from the five ratings firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued ratings on the stock in […]

United statesAndrew guggenhimeNeedham companyBridgefront capitalVanguard personalized indexing managementVaxcyte incGroupa streptococcusRussell investments group ltdCantor fitzgeraldGet free reportInvestments groupGet freeVaxcyte dailyNasdaq pcvx